Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy

Published:2014-08 Issue:8 Volume:12 Page:1390-1397.e2
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Mullen Kevin D.,Sanyal Arun J.,Bass Nathan M.,Poordad Fred F.,Sheikh Muhammad Y.,Frederick R. Todd,Bortey Enoch,Forbes William P.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers;Bajaj;Am J Gastroenterol,2011

2. Review article: the burden of hepatic encephalopathy;Poordad;Aliment Pharmacol Ther,2007

3. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension;Nguyen;Clin Gastroenterol Hepatol,2007

4. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease;Stewart;Liver Transpl,2007

5. Prognostic significance of hepatic encephalopathy in patients with cirrhosis;Bustamante;J Hepatol,1999

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rifaximin: A Comprehensive Review of Structure, Uses, Mechanisms of Action, and Assay Methods;Journal for Research in Applied Sciences and Biotechnology;2024-07-15

2. B-ultrasound-guided Intrahepatic Infusion of Autologous Bone Marrow Cells for Decompensated Cirrhosis;International Journal of Bone Marrow Research;2024-07-12

3. Preventing Readmissions of Hepatic Encephalopathy;Clinics in Liver Disease;2024-05

4. Pathophysiology of Hepatic Encephalopathy;Clinics in Liver Disease;2024-05

5. Comparison of Rifaximin Alone and With Quinolones in the Primary Prevention of Spontaneous Bacterial Peritonitis in Patients With Decompensated Chronic Liver Disease;Cureus;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3